Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 April 2025 | Story Precious Shamase | Photo Supplied
Robson Nkosi
Robson Nkosi in his academic regalia at the graduation for his honours degree.

Robson Siphosihle Nkosi's journey is a compelling narrative of resilience, determination, and academic achievement – a story that resonates deeply within the University of the Free State (UFS) community. Born in Mpumalanga and raised under challenging circumstances, Nkosi's path to academic success is a testament to his unwavering spirit.

 

Unwavering determination

His early life was marked by significant loss, having been raised initially by his grandmother, and subsequently by his mother, who tragically passed away just before his final year of high school at Bee Maseko Secondary School, a quintile 1 school in Sheepmoor, Mpumalanga. Facing financial hardship, he relied on the support of friends to complete his matriculation.

Despite these adversities, Nkosi's determination shone through. With the invaluable assistance of his high school teacher, Mokoena Libakiso – whom he now considers his mother – he applied to the UFS to pursue a teaching degree. Although initially accepted, funding delays resulted in his offer being withdrawn. Securing funding later, he enrolled in a BSocSci degree, majoring in Communication Science and Sociology, demonstrating his adaptability and commitment to higher education.

Nkosi’s initial aspiration to switch to a Bachelor of Education degree was redirected by the NSFAS N+1 rule. However, he refocused his goals, setting his sights on a PhD and a career in higher education lecturing. This strategic vision fuelled his academic pursuits.


Leadership. Excellence. PhD.

His leadership skills were honed during his final undergraduate year, serving as the Qwaqwa Campus SRC Deputy President and ISRC Treasurer General. His academic excellence was consistently recognised through academic merit bursaries and the UFS Partial Tuition Fee Bursary, which supported his honours studies. Living in Botshabelo and commuting to Bloemfontein, Nkosi demonstrated his dedication.

During his honours year, he not only excelled as a student, but also as a tutor and Career Ambassador. His academic prowess led to an invitation from his honours lecturer, Yzelle Du Plessis, to facilitate Communication Science classes. He completed his honours degree cum laude, specialising in Leadership Communication.

Nkosi's academic journey continued with a master’s in communication science, funded by the National Research Foundation (NRF). Simultaneously, he gained practical teaching experience as a junior lecturer. He recently completed his master's degree and is now pursuing a PhD in Communication Science, while continuing to teach final-year and honours students on the Bloemfontein Campus.


A life dedicated to education and leadership

His short-term goal is to secure a permanent lecturing position, while his long-term ambition is to become a professor of Communication Science and potentially assume a leadership role in higher education, the public sector, or civil society.

Robson Nkosi's story is a powerful example of resilience, academic excellence, and the transformative impact of education. His dedication and gratitude to those who supported him underscore the importance of community and mentorship. He stands as an inspiration to the UFS community, demonstrating that with determination and perseverance, even the most challenging circumstances can be overcome.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept